User:DorotheaSigel: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

15 November 2024

  • curprev 18:5418:54, 15 November 2024‎ DorotheaSigel talk contribs‎ 8,867 bytes +8,867‎ Created page with "A vital transporter answerable for kidney glucose reabsorption, dapagliflozin is a strong, extremely selective and by mouth energetic suppressor of the human kidney sodium glucose cotransporter type 2 (SGLT2) [92] A medical trial of dapagliflozin in pediatric people aged 10-- 17 years for the therapy of type 2 diabetes mellitus has actually been performed, however professional tests of this drug for pediatric or young adult weight problems is not defined [94] In clinical..."
Retrieved from "https://geislingen.wiki/wiki/User:DorotheaSigel"